Thus, celecoxib may affect both apoptosis induction and MDR1 down-regulation by inhibiting the Akt/NF-κB pathway, resulting in an enhanced anti-tumor effects of not only SDT but also other anti-tumor agents. Here, ABCB1 is linked to neoplasm.